These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 32500409)

  • 21. How did COVID-19 pandemic changed the Portuguese rheumatology?
    Vieira-Sousa E; Fonseca JE; Santos MJ
    Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
    Ghosh N; Tirpack A; Chan KK; Bass AR
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.
    Mukusheva Z; Assylbekova M; Poddighe D
    Rheumatol Int; 2020 Aug; 40(8):1351-1352. PubMed ID: 32514608
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.
    Elera-Fitzcarrald C; Ugarte-Gil MF; Alarcón GS
    J Clin Rheumatol; 2020 Sep; 26(6):215-217. PubMed ID: 32511148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
    Ietto G
    Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.
    Seo MR; Kim JW; Park EJ; Jung SM; Sung YK; Kim H; Kim G; Kim HS; Lee MS; Lee J; Hur JA; Chin BS; Eom JS; Baek HJ;
    Korean J Intern Med; 2020 Nov; 35(6):1317-1332. PubMed ID: 32972125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis.
    Meenakshisundaram R; Senthilkumaran S; Thirumalaikolundusubramanian P
    Med Hypotheses; 2020 Oct; 143():109849. PubMed ID: 32480250
    [No Abstract]   [Full Text] [Related]  

  • 33. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
    Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
    Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Whitehead CL; Walker SP
    Lancet; 2020 May; 395(10237):e92. PubMed ID: 32410758
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].
    Janda A; Schuetz C; Heeg M; Minden K; Hedrich CM; Kallinich T; Hinze C; Schulz A; Speth F
    Z Rheumatol; 2020 Sep; 79(7):710-717. PubMed ID: 32809050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
    Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
    Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
    Ehtesham NZ; Samal J; Ahmad F; Arish M; Naz F; Alam A; Agrawal U; Hasnain SE
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):16-20. PubMed ID: 32859863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.